Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Celgene Corp (NASDAQ: CELG)

Last Updated: Feb-22-2017 09:13:03

Premium Research

Celgene Corp (NASDAQ: CELG) Profile

Prior Close$119.44
Market Cap$92.56 B
PE Ratio23.03
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery development and commercialization of orally administered small molecule drugs for the treatment of cancer and immunological diseases.
SymbolCompanyMarket cap
AMGNAmgen$127.62 B
GILDGilead Sciences Inc$91.5 B
BIIBBiogen Inc Cmn$62.4 B
REGNRegeneron Pharmaceutical$39.15 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$28.93 B
ILMNIllumina Inc$23.9 B
INCYIncyte Corporation$22.82 B
VRTXVertex Pharmaceutic$21.93 B
BMRNBiomarin Pharmaceut$15.46 B

CELG Earnings

1st Quarter Earnings$1.61 (2017-01-26)
2nd Quarter Earnings$1.58 (2016-10-27)
3rd Quarter Earnings$1.44 (2016-07-28)
4th Quarter Earnings$1.32 (2016-04-28)
PE Ratio23.03
EPS Growth27.46%
Recent Earnings$1.61
Annual EPS$5.26
Market Capitalization$92.56 B
Insider Shareholder %0.0097%
Annual Revenue$11.23 B
Number of Shares Outstanding777,970 Shares
Institutional Shareholder %77.68%
Annual Net Income$2B
TTM Net Profit Margin$17.8
One Year Return17.05%
Three Year Return45.58%
Five Year Return218.97%
Five Year Revenue Growth131.91%
Five Year Earnings Growth201.16%
Five Year Dividend Growth0%
Last Quarter EPS$0.53
Annual EPS$5.26
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD27.459999%
PE Ratio23.03
Recent Earnings$1.61
Dividends per Share$
Stock Split Ratio2-1

CELG Key Stats

Last Price$118.98
Net Change$-0.46 (-0.39%)
Ask Price$119.02
Open Price$119.48
Previous Close Price$119.44
High Price$119.85
Low Price$118.87
Number of Trades2,216
Fifty Two Week High$127 (2016-11-09)
Fifty Two Week Low$94.39 (2016-03-17)
Average Daily Volume4,268,791
Share Outstanding777,970 Shares
Total Dividend Payout$0/yr
Dividend Yield0%